Difference between revisions of "Adenosquamous carcinoma of the lung"

From Libre Pathology
Jump to navigation Jump to search
Line 45: Line 45:


===Images===
===Images===
www:
<gallery>
Image: Adenosquamous carcinoma of lung -- intermed mag.jpg | ASC with SC - intermed. mag.  (WC)
Image: Adenosquamous carcinoma of lung - alt -- intermed mag.jpg | ASC with SC - intermed. mag. (WC)
Image: Adenosquamous carcinoma of lung -- high mag.jpg | ASC with SC - high mag. (WC)
Image: Adenosquamous carcinoma of lung -- very high mag.jpg | ASC with SC - very high mag. (WC)
</gallery>
====www====
*[http://www.webpathology.com/image.asp?case=415&n=21 Lung adenosquamous carcinoma (webpathology.com)].
*[http://www.webpathology.com/image.asp?case=415&n=21 Lung adenosquamous carcinoma (webpathology.com)].
*[https://www.flickr.com/photos/pulmonary_pathology/7491350926/ Lung adenosquamous carcinoma (flickr.com/Yale Rosen)].
*[https://www.flickr.com/photos/pulmonary_pathology/7491350926/ Lung adenosquamous carcinoma (flickr.com/Yale Rosen)].

Revision as of 05:34, 29 December 2015

Adenosquamous carcinoma of the lung
Diagnosis in short

Adenosquamous carcinoma of lung. H&E stain.
LM DDx squamous cell carcinoma of the lung, adenocarcinoma of the lung
Site lung - see lung tumours

Prevalence rare
Clin. DDx other lung tumours

Adenosquamous carcinoma of the lung, also lung adenosquamous carcinoma, is a rare epithelial derived malignancy of the lung with features of both adenocarcinoma and squamous cell carcinoma.

It is grouped with the non-small cell lung cancers.

General

Microscopic

Features:

  1. Adenocarcinoma component.
  2. Squamous cell carcinoma component.

Images

www

See also

References

  1. Song, Z.; Lin, B.; Shao, L.; Zhang, Y. (Sep 2013). "Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma.". J Chin Med Assoc 76 (9): 481-5. doi:10.1016/j.jcma.2013.05.007. PMID 23769878.
  2. Iwanaga, K.; Sueoka-Aragane, N.; Nakamura, T.; Mori, D.; Kimura, S. (2012). "The long-term survival of a patient with adenosquamous lung carcinoma harboring EGFR-activating mutations who was treated with gefitinib.". Intern Med 51 (19): 2771-4. PMID 23037472.